Showing results (121-130 of 135) with videos related to
Sort By:
Pageof 14
Journal of the American Academy of Child and Adolescent Psychiatry|March 1, 1991
A follow-up of female delinquents: maternal contributions to the perpetuation of devianceD O Lewis, C A Yeager, C S Cobham-Portorreal, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
An autologous oral DNA vaccine protects against murine melanomaR Xiang, H N Lode, T H Chao, et al.Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.The American Journal of Psychiatry|May 1, 1988
Neuropsychiatric, psychoeducational, and family characteristics of 14 juveniles condemned to death in the United StatesD O Lewis, J H Pincus, B Bard, et al.The American Journal of Psychiatry|December 1, 1987
Bipolar mood disorder and endometriosis: preliminary findingsD O Lewis, F Comite, C Mallouh, et al.Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.Journal of the National Cancer Institute|December 23, 1998
Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigensS A Rosenberg, Y Zhai, J C Yang, et al.Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.Pageof 14